Skip to content

Validity of (FEV3-FEV1)/FVC in airway hyperresponsiveness prediction

(FEV3-FEV1)/FVC: a terminal-airflow variable for airway hyperresponsiveness and inflammation prediction in patients with symptoms despite preserved spirometry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075350
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

Trail group:None

Sponsors

SHANGHAI GENERAL HOSPOTAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.Age from 18 to 70 years 2.With recurrent variable symptoms of dyspnea, cough, wheeze, or chest tightness of at least 8 weeks’ duration. 3.Have undergone the spirometry and methacholine (MCH) bronchoprovocation test, IOS, FENO, and high-resolution computerized tomography (HRCT, GE Medical System; slice thickness 0.625 mm) from September 2013 to December 2019. 4.predicted FEV1 of 80% or greater and FEV1/FVC=0.7, normal HRCT results.

Exclusion criteria

Exclusion criteria: 1.Had respiratory tract infections in the past 8 weeks; 2.Peripheral blood test indicating abnormal hemoglobin, platelets or neutrophils; 3.Use of montelukast, long-acting ß2-agonists, theophylline, anticholinergic agents, or inhaled or oral corticosteroids in the previous 4 weeks; 4.Having concomitant severe systemic diseases. 5.Had more than a 10 pack-year smoking history, who currently smoked, or who had quit smoking less than 2 years earlier.

Design outcomes

Primary

MeasureTime frame
spirometry(FEV3-FEV1)/FVC;

Secondary

MeasureTime frame
MCH BPT: methacholine bronchoprovocation test;IOS: impulse oscillometry;FENO: fractional exhaled nitric oxide;

Countries

China

Contacts

Public ContactMin Zhang

Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

maggie_zhangmin@163.com+86 134 8234 5145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026